Question 1

When is it appropriate to conduct a longer-than-average survey?

Accepted Answer

It's appropriate to field a longer-than-average survey only when the target audience is highly motivated or specialized enough to handle the extra length. For instance, B2B professionals or enthusiasts on a niche topic might willingly spend 30+ minutes on a survey if they find the subject matter relevant and engaging. In such cases, it's critical to communicate the time commitment up front and ensure the survey is well-structured - perhaps broken into clear sections with progress indicators - to keep people engaged. A longer survey should earn its length: every question must serve a purpose and ideally provide value or insight to the respondent as well. Often researchers will offer a strong incentive or the promise of seeing the study results, as appreciation for the respondent's time. In summary, go long only when you have the right audience and design to support it.

Question 2

How are decentralized trials reshaping patient recruitment and engagement?

Accepted Answer

Decentralized clinical trials are broadening patient recruitment and boosting engagement by making participation more accessible and convenient, even for those with mobility or scheduling constraints. By allowing patients to join studies from home or local clinics, these trials remove geographic barriers-a rural patient, for instance, can enroll via a phone app and telemedicine instead of traveling to a distant site. This approach attracts more diverse participants and keeps them engaged via telehealth visits, wearable devices, and app-based reminders, improving adherence since the trial fits into daily life. The shift toward a patient-centric design leads to higher retention and a better experience overall compared to traditional site-based trials, though sponsors must ensure the technology and support remain user-friendly for all participants.

Question 3

Will AI summaries replace browseable decks in democratization programs?

Accepted Answer

Artificial Intelligence (AI)-generated summaries (often powered by large language models) offer a powerful way to distill insights, but they likely won't completely replace browseable decks in democratization programs. A concise AI summary can give busy stakeholders quick answers or highlight key findings, making data feel more accessible. However, interactive decks or dashboards let users explore details, see visuals, and drill into areas of interest-capabilities a static summary can't fully provide. There's also nuance: an AI might oversimplify or miss context that a well-crafted slide deck or report includes. In practice, AI summaries are emerging as a complement to traditional deliverables: the AI can provide instant, chat-like answers to specific questions, while the detailed deck remains available for deeper dives. Together, they serve different needs in insight democratization rather than one completely replacing the other.

Question 4

How do I forecast prescribing behavior based on physician awareness?

Accepted Answer

To forecast prescribing behavior based on physician awareness, incorporate awareness as a key input in a predictive model informed by past patterns. Start by measuring current awareness levels of the drug among the target physicians (through surveys or awareness tracking). Then use analogs or historical data: for example, examine similar drug launches to see how prescription volumes grew once physician awareness hit certain thresholds. You might find that when, say, 70% of doctors were aware of a comparable drug, it achieved a 30% adoption rate in its category. Such relationships allow you to estimate how rising awareness for your drug could translate into new prescriptions. If you have data on physicians' intent-to-prescribe (like survey respondents indicating how likely they are to prescribe after becoming aware), include that as well for refinement. In practice, you'll likely build a simple model or assumption set where each percentage gain in awareness contributes a proportional gain in prescribing, adjusted for factors like drug efficacy and market access. Regularly update the forecast with actual prescription data as awareness grows, refining the model over time.

Question 5

How do I simplify explanations of experimental designs for stakeholders?

Accepted Answer

Simplify explanations of experimental design by using everyday language, relatable examples, and focusing on the why rather than technical jargon. For instance, instead of saying "we used a 2x2 factorial experiment with a control," you could explain, "we tested a couple of different approaches by splitting customers into groups at random, like a mini science experiment, to see which approach worked best." Analogies can help: comparing a marketing test to a medical trial (where one group gets a new treatment and another doesn't) makes the concept concrete. Visual aids like a simple flowchart of how people were assigned to test vs. control can also clarify the design. Above all, emphasize what the design achieves (fair comparison, reliable results) in plain terms, so stakeholders understand the value of the method without needing a stats degree.

decodeMR

Why choose Us

What is decodeMR?

Services and Expertise

Market Research FAQs with Expert Insights

When is it appropriate to conduct a longer-than-average survey?

How are decentralized trials reshaping patient recruitment and engagement?

Will AI summaries replace browseable decks in democratization programs?

How do I forecast prescribing behavior based on physician awareness?

How do I simplify explanations of experimental designs for stakeholders?